Braidwell LP Acquires New Shares in UnitedHealth Group Incorporated $UNH

Braidwell LP bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 49,400 shares of the healthcare conglomerate’s stock, valued at approximately $15,411,000.

Several other institutional investors have also modified their holdings of UNH. Forefront Analytics LLC raised its holdings in UnitedHealth Group by 4.2% during the 1st quarter. Forefront Analytics LLC now owns 820 shares of the healthcare conglomerate’s stock worth $430,000 after buying an additional 33 shares during the period. TFB Advisors LLC raised its holdings in shares of UnitedHealth Group by 2.7% during the first quarter. TFB Advisors LLC now owns 1,272 shares of the healthcare conglomerate’s stock worth $666,000 after acquiring an additional 33 shares during the period. Bank OZK boosted its stake in UnitedHealth Group by 4.6% in the 1st quarter. Bank OZK now owns 766 shares of the healthcare conglomerate’s stock worth $401,000 after purchasing an additional 34 shares during the period. GK Wealth Management LLC raised its stake in shares of UnitedHealth Group by 7.2% in the 1st quarter. GK Wealth Management LLC now owns 506 shares of the healthcare conglomerate’s stock valued at $265,000 after purchasing an additional 34 shares during the period. Finally, Western Pacific Wealth Management LP boosted its position in shares of UnitedHealth Group by 12.0% during the second quarter. Western Pacific Wealth Management LP now owns 336 shares of the healthcare conglomerate’s stock worth $105,000 after buying an additional 36 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $341.83 on Friday. The firm has a market capitalization of $309.65 billion, a PE ratio of 17.84, a PEG ratio of 2.20 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The company’s 50-day moving average is $339.84 and its 200-day moving average is $316.91. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s revenue was up 12.2% on a year-over-year basis. During the same period in the prior year, the firm earned $7.15 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Piper Sandler decreased their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Mizuho lifted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Royal Bank Of Canada raised their price objective on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Sanford C. Bernstein upped their target price on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Finally, Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Seventeen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $385.54.

Check Out Our Latest Analysis on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.